BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Diop-Ndiaye H, Touré-Kane C, Etard JF, Lô G, Diaw P, Ngom-Gueye NF, Gueye PM, Ba-Fall K, Ndiaye I, Sow PS, Delaporte E, Mboup S. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). J Med Virol 2008;80:1332-6. [PMID: 18551596 DOI: 10.1002/jmv.21236] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Coffie PA, Patassi A, Doumbia A, Bado G, Messou E, Minga A, Allah-Kouadio E, Zannou DM, Seydi M, Kakou AR, Dabis F, Wandeler G. Changes in viral hepatitis B screening practices over time in West African HIV clinics. Med Mal Infect 2017;47:394-400. [PMID: 28545675 DOI: 10.1016/j.medmal.2017.04.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Atsbaha AH, Asmelash Dejen T, Belodu R, Getachew K, Saravanan M, Wasihun AG. Sero-prevalence and associated risk factors for hepatitis C virus infection among voluntary counseling testing and anti retroviral treatment clinic attendants in Adwa hospital, northern Ethiopia. BMC Res Notes 2016;9:121. [PMID: 26905429 DOI: 10.1186/s13104-016-1936-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
3 Oluremi AS, Opaleye OO, Ogbolu DO, Alli OAT, Ashiru FT, Alaka OO, Suleiman IE, Enitan SS, Adelakun AA, Adediji IO, Olowoyeye EA, Adewumi OO, Ayodele TO, Ogunleke OA. Serological evidence of HIV, Hepatitis B, C, and E viruses among liver disease patients attending tertiary hospitals in Osun State, Nigeria. J Immunoassay Immunochem 2021;42:69-81. [PMID: 32967530 DOI: 10.1080/15321819.2020.1821214] [Reference Citation Analysis]
4 Basnayake SK, Easterbrook PJ. Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature. J Viral Hepat 2016;23:545-59. [PMID: 27028545 DOI: 10.1111/jvh.12519] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]
5 Dovonou CA, Amidou SA, Kpangon AA, Traoré YA, Godjedo TP, Satondji AJ, Wachinou AP, Issa-Djibril FM, Fourn L, Zannou DM, Gandaho P. [Prevalence of hepatitis B in people infected with HIV in Parakou in Benin]. Pan Afr Med J 2015;20:125. [PMID: 26097629 DOI: 10.11604/pamj.2015.20.125.6061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
6 Matthews GV, Manzini P, Hu Z, Khabo P, Maja P, Matchaba G, Sangweni P, Metcalf J, Pool N, Orsega S, Emery S; PHIDISA II study team. Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa. AIDS 2011;25:1727-35. [PMID: 21716078 DOI: 10.1097/QAD.0b013e328349bbf3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
7 Platt L, French CE, McGowan CR, Sabin K, Gower E, Trickey A, McDonald B, Ong J, Stone J, Easterbrook P, Vickerman P. Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysis. J Viral Hepat. 2020;27:294-315. [PMID: 31603999 DOI: 10.1111/jvh.13217] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
8 Tajik Z, Bokharaei-Salim F, Ghorbani S, Keyvani H, Esghaei M, Monavari SH, Ataei-Pirkooh A, Garshasbi S, Donyavi T, Fakhim A. Detection of HBV genome in the plasma and peripheral blood mononuclear cells of Iranian HBsAg negative patients with HIV infection: occult HBV infection. Arch Virol 2018;163:1559-66. [PMID: 29476259 DOI: 10.1007/s00705-018-3740-y] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Geretti AM, Patel M, Sarfo FS, Chadwick D, Verheyen J, Fraune M, Garcia A, Phillips RO. Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana. J Clin Microbiol. 2010;48:3223-3230. [PMID: 20631103 DOI: 10.1128/jcm.02231-09] [Cited by in Crossref: 67] [Cited by in F6Publishing: 35] [Article Influence: 5.6] [Reference Citation Analysis]
10 Hønge B, Jespersen S, Medina C, Té D, da Silva Z, Ostergaard L, Laursen A, Wejse C, Krarup H, Erikstrup C; Bissau HIV cohort study group. Hepatitis B virus surface antigen and anti-hepatitis C virus rapid tests underestimate hepatitis prevalence among HIV-infected patients. HIV Med 2014;15:571-6. [PMID: 24717010 DOI: 10.1111/hiv.12158] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
11 Coste M, De Sèze M, Diallo A, Carrieri MP, Marcellin F, Boyer S; ANRS 12356 AmBASS Study Group. Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356). BMJ Open 2019;9:e030211. [PMID: 31320358 DOI: 10.1136/bmjopen-2019-030211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Barth RE, Huijgen Q, Taljaard J, Hoepelman AI. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis. 2010;14:e1024-e1031. [PMID: 20870439 DOI: 10.1016/j.ijid.2010.06.013] [Cited by in Crossref: 117] [Cited by in F6Publishing: 118] [Article Influence: 9.8] [Reference Citation Analysis]
13 Jaquet A, Wandeler G, Nouaman M, Ekouevi DK, Tine J, Patassi A, Coffie PA, Tanon A, Seydi M, Attia A, Dabis F. Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study. J Int AIDS Soc 2017;19:21424. [PMID: 28362065 DOI: 10.7448/IAS.20.1.21424] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
14 Ferrante ND, Lo Re V 3rd. Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection. Curr HIV/AIDS Rep. 2020;17:405-414. [PMID: 32607773 DOI: 10.1007/s11904-020-00508-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Tremeau-Bravard A, Ogbukagu IC, Ticao CJ, Abubakar JJ. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria. Afr Health Sci 2012;12:312-7. [PMID: 23382745 DOI: 10.4314/ahs.v12i3.10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 0.4] [Reference Citation Analysis]
16 Wang HS, Han SB. Management of Hepatitis B in Special Patient Populations. Clinics in Liver Disease 2010;14:505-20. [DOI: 10.1016/j.cld.2010.05.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
17 Olawumi HO, Olanrewaju DO, Shittu AO, Durotoye IA, Akande AA, Nyamngee A. Effect of hepatitis-B virus co-infection on CD4 cell count and liver function of HIV infected patients. Ghana Med J. 2014;48:96-100. [PMID: 25667557 DOI: 10.4314/gmj.v48i2.7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
18 Stockdale AJ, Chaponda M, Beloukas A, Phillips RO, Matthews PC, Papadimitropoulos A, King S, Bonnett L, Geretti AM. Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health 2017;5:e992-e1003. [PMID: 28911765 DOI: 10.1016/S2214-109X(17)30298-X] [Cited by in Crossref: 58] [Cited by in F6Publishing: 21] [Article Influence: 14.5] [Reference Citation Analysis]
19 Kapembwa KC, Goldman JD, Lakhi S, Banda Y, Bowa K, Vermund SH, Mulenga J, Chama D, Chi BH. HIV, Hepatitis B, and Hepatitis C in Zambia. J Glob Infect Dis. 2011;3:269-274. [PMID: 21887060 DOI: 10.4103/0974-777x.83534] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
20 Hønge BL, Jespersen S, Medina C, Té Dda S, da Silva ZJ, Lewin S, Østergaard L, Erikstrup C, Wejse C, Laursen AL, Krarup H; Bissau HIV cohort study group. Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study. PLoS One 2014;9:e99971. [PMID: 24915064 DOI: 10.1371/journal.pone.0099971] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
21 Andernach IE, Leiss LV, Tarnagda ZS, Tahita MC, Otegbayo JA, Forbi JC, Omilabu S, Gouandjika-Vasilache I, Komas NP, Mbah OP, Muller CP. Characterization of hepatitis delta virus in sub-Saharan Africa. J Clin Microbiol. 2014;52:1629-1636. [PMID: 24599979 DOI: 10.1128/jcm.02297-13] [Cited by in Crossref: 48] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
22 Coffie PA, Tchounga BK, Bado G, Kabran M, Minta DK, Wandeler G, Gottlieb GS, Dabis F, Eholie SP, Ekouevi DK. Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa. BMC Infect Dis 2017;17:466. [PMID: 28676076 DOI: 10.1186/s12879-017-2568-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
23 Katwesigye E, Seremba E, Semitala F, Ocama P. Low sero-prevalence of hepatitis delta antibodies in HIV/ hepatitis B co-infected patients attending an urban HIV clinic in Uganda. Afr Health Sci 2016;16:1089-93. [PMID: 28479902 DOI: 10.4314/ahs.v16i4.26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
24 Taddei TH, Lo Re V 3rd, Justice AC. HIV, Aging, and Viral Coinfections: Taking the Long View. Curr HIV/AIDS Rep 2016;13:269-78. [PMID: 27614654 DOI: 10.1007/s11904-016-0327-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
25 Okwen MP, Reid S, Njei B, Mbuagbaw L. Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infection. Cochrane Database Syst Rev 2014;:CD009886. [PMID: 25300375 DOI: 10.1002/14651858.CD009886.pub2] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
26 Wondimeneh Y, Alem M, Asfaw F, Belyhun Y. HBV and HCV seroprevalence and their correlation with CD4 cells and liver enzymes among HIV positive individuals at University of Gondar Teaching Hospital, Northwest Ethiopia. Virol J 2013;10:171. [PMID: 23721493 DOI: 10.1186/1743-422X-10-171] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
27 Ndiaye O, Gozlan J, Diop-Ndiaye H, Sall AS, Chapelain S, Leprêtre A, Maynart M, Gueye M, Lo G, Thiam M, Ba I, Lacombe K, Girard PM, Mboup S, Kane CT. Usefulness of Dried Blood Spots (DBS) to perform hepatitis C virus genotyping in drug users in Senegal. J Med Virol 2017;89:484-8. [PMID: 26705258 DOI: 10.1002/jmv.24460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Parikh N, Nonnemacher MR, Pirrone V, Block T, Mehta A, Wigdahl B. Substance abuse, HIV-1 and hepatitis. Curr HIV Res 2012;10:557-71. [PMID: 22973853 DOI: 10.2174/157016212803306023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
29 Dziuban EJ, Marton SA, Hughey AB, Mbingo TL, Draper HR, Schutze GE. Seroprevalence of hepatitis B in a cohort of HIV-infected children and adults in Swaziland. Int J STD AIDS 2013;24:561-5. [DOI: 10.1177/0956462413476274] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
30 Sagoe KW, Duedu KO, Ziga F, Agyei AA, Adiku TK, Lartey M, Mingle JA, Arens M. Short-term treatment outcomes in human immunodeficiency virus type-1 and hepatitis B virus co-infections. Ann Clin Microbiol Antimicrob 2016;15:38. [PMID: 27251610 DOI: 10.1186/s12941-016-0152-2] [Reference Citation Analysis]
31 Sagoe KW, Agyei AA, Ziga F, Lartey M, Adiku TK, Seshi M, Arens MQ, Mingle JA. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana. J Med Virol 2012;84:6-10. [PMID: 22095533 DOI: 10.1002/jmv.22262] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
32 Muriuki BM, Gicheru MM, Wachira D, Nyamache AK, Khamadi SA. Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya. BMC Res Notes 2013;6:363. [PMID: 24016453 DOI: 10.1186/1756-0500-6-363] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
33 Olawumi HO, Olanrewaju DO, Shittu AO, Durotoye IA, Akande AA, Nyamngee A. Effect of Hepatitis B Virus Co-Infection on CD4 Cell Count and Liver Function of HIV Infected Patients. Ghana Med J 2015;49:2-6. [PMID: 26339077 DOI: 10.4314/gmj.v49i1.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
34 Sow A, Lemoine M, Toure PS, Diop M, Lo G, De Veiga J, Pape OT, Seck K, Ndow G, Bojang L, Kane A, Oudiane M, Howell J, Nayagam S, Moutchia J, Chemin I, Mendy M, Toure-kane C, Thursz M, Ka M, Shimakawa Y, Mboup S. HBV continuum of care using community- and hospital-based screening interventions in Senegal. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100533] [Reference Citation Analysis]
35 Thio CL, Smeaton L, Hollabaugh K, Saulynas M, Hwang H, Saravanan S, Kulkarni S, Hakim J, Nyirenda M, Iqbal HS, Lalloo UG, Campbell TB, Lockman S, Currier JS. Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks. AIDS 2015;29:1173-82. [PMID: 26035319 DOI: 10.1097/QAD.0000000000000686] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
36 Stabinski L, O’Connor S, Barnhart M, Kahn RJ, Hamm TE. Prevalence of HIV and hepatitis B virus co-infection in sub-Saharan Africa and the potential impact and program feasibility of hepatitis B surface antigen screening in resource-limited settings. J Acquir Immune Defic Syndr. 2015;68 Suppl 3:S274-S285. [PMID: 25768867 DOI: 10.1097/qai.0000000000000496] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
37 Jaquet A, Wandeler G, Tine J, Diallo MB, Manga NM, Dia NM, Fall F, Dabis F, Seydi M. Prevention and Care of Hepatitis B in Senegal; Awareness and Attitudes of Medical Practitioners. Am J Trop Med Hyg 2017;97:389-95. [PMID: 28829726 DOI: 10.4269/ajtmh.17-0065] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
38 Gachara G, Magoro T, Mavhandu L, Lum E, Kimbi HK, Ndip RN, Bessong PO. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon. AIDS Res Ther 2017;14:11. [PMID: 28270215 DOI: 10.1186/s12981-017-0136-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
39 Newton OE, Oghene OA, Okonko IO. Anti-HCV antibody among newly diagnosed HIV patients in Ughelli, a suburban area of Delta State Nigeria. Afr Health Sci 2015;15:728-36. [PMID: 26957959 DOI: 10.4314/ahs.v15i3.5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
40 Thio CL, Smeaton L, Saulynas M, Hwang H, Saravanan S, Kulkarni S, Hakim J, Nyirenda M, Iqbal HS, Lalloo UG, Mehta AS, Hollabaugh K, Campbell TB, Lockman S, Currier JS. Characterization of HIV-HBV coinfection in a multinational HIV-infected cohort. AIDS 2013;27:191-201. [PMID: 23032418 DOI: 10.1097/QAD.0b013e32835a9984] [Cited by in Crossref: 66] [Cited by in F6Publishing: 42] [Article Influence: 7.3] [Reference Citation Analysis]
41 Luma HN, Eloumou SA, Ekaney DS, Lekpa FK, Donfack-Sontsa O, Ngahane BH, Mapoure YN. Sero-prevalence and Correlates of Hepatitis B and C Co-infection Among HIV-infected Individuals in Two Regional Hospitals in Cameroon. Open AIDS J 2016;10:199-208. [PMID: 27867437 DOI: 10.2174/1874613601610010199] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
42 Lô G, Sow-Sall A, Diop-Ndiaye H, Mandiouba NC, Thiam M, Diop F, Ndiaye O, Gueye SB, Seck SM, Dioura AA, Mbow M, Gaye-Diallo A, Mboup S, Touré-Kâne C. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients. J Med Virol 2016;88:461-5. [PMID: 26252424 DOI: 10.1002/jmv.24344] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
43 Yendewa GA, Lakoh S, Yendewa SA, Bangura K, Lawrence H, Patiño L, Jiba DF, Vandy AO, Murray MJS, Massaquoi SP, Deen GF, Sahr F, Hoffmann CJ, Jacobson JM, Poveda E, Aguilera A, Salata RA. Prevalence of hepatitis B surface antigen and serological markers of other endemic infections in HIV-infected children, adolescents and pregnant women in Sierra Leone: A cross-sectional study. Int J Infect Dis 2021;102:45-52. [PMID: 33002619 DOI: 10.1016/j.ijid.2020.09.1459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Attia KA, Eholié S, Messou E, Danel C, Polneau S, Chenal H, Toni T, Mbamy M, Seyler C, Wakasugi N, N’dri-Yoman T, Anglaret X. Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients. World J Hepatol 2012; 4(7): 218-223 [PMID: 22855697 DOI: 10.4254/wjh.v4.i7.218] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
45 Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology 2009;49:S138-45. [PMID: 19399813 DOI: 10.1002/hep.22883] [Cited by in Crossref: 200] [Cited by in F6Publishing: 192] [Article Influence: 15.4] [Reference Citation Analysis]
46 Périères L, Diallo A, Marcellin F, Nishimwe ML, Ba EH, Coste M, Lo G, Halfon P, Touré Kane C, Maradan G, Carrieri P, Diouf A, Shimakawa Y, Sokhna C, Boyer S; ANRS 12356 AmBASS Survey Study Group. Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey). Hepatol Commun 2021. [PMID: 34918868 DOI: 10.1002/hep4.1879] [Reference Citation Analysis]
47 Jobarteh M, Malfroy M, Peterson I, Jeng A, Sarge-Njie R, Alabi A, Peterson K, Cotten M, Hall A, Rowland-Jones S. Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians. Virol J. 2010;7:230. [PMID: 20843322 DOI: 10.1186/1743-422x-7-230] [Cited by in Crossref: 38] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
48 Van der Linden D, Cotton M, Rabie H, McKerrow N. Fatal hepatitis B infection despite immunization in an HIV-infected infant: a possible case of vaccine failure and immune reconstitution inflammatory syndrome. J Trop Pediatr 2010;56:351-4. [PMID: 20159888 DOI: 10.1093/tropej/fmq003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Katwesigye E, Seremba E, Semitala F, Ocama P. Low sero-prevalence of hepatitis delta antibodies in HIV/ hepatitis B co-infected patients attending an urban HIV clinic in Uganda. Afr Health Sci 2017;17:974-8. [PMID: 29937867 DOI: 10.4314/ahs.v17i4.4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
50 Boateng R, Mutocheluh M, Dompreh A, Obiri-Yeboah D, Odame Anto E, Owusu M, Narkwa PW. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana. PLoS One 2019;14:e0215377. [PMID: 31002687 DOI: 10.1371/journal.pone.0215377] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
51 Hønge BL, Jespersen S, Medina C, da Silva Té D, da Silva ZJ, Lewin SR, Østergaard L, Laursen AL, Krarup H, Erikstrup C, Wejse C; Bissau HIV Cohort Study Group. Hepatitis C prevalence among HIV-infected patients in Guinea-Bissau: a descriptive cross-sectional study. Int J Infect Dis 2014;28:35-40. [PMID: 25223805 DOI: 10.1016/j.ijid.2014.06.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
52 Kye-Duodu G, Nortey P, Malm K, Nyarko KM, Sackey SO, Ofori S, Afari EA. Prevalence of hepatitis B virus co-infection among HIV-seropositive persons attending antiretroviral clinics in the Eastern Region of Ghana. Pan Afr Med J 2016;25:7. [PMID: 28210375 DOI: 10.11604/pamj.supp.2016.25.1.6172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
53 Jiao Y, Li N, Chen X, Zhang T, Li H, Li W, Huang X, Liu Z, Zhang Y, Wu H. Acute HIV infection is beneficial for controlling chronic hepatitis B. Clin Infect Dis 2015;60:128-34. [PMID: 25205770 DOI: 10.1093/cid/ciu710] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
54 Aghakhani A, Mohraz M, Aghasadeghi MR, Banifazl M, Vahabpour R, Karami A, Foroughi M, Ramezani A. Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination. Int J STD AIDS 2016;27:967-72. [DOI: 10.1177/0956462415602419] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
55 Bado G, Penot P, N'Diaye MD, Amiel C, Hema A, Kamboulé EB, Guiard-Schmid JB, Kaboré NF, Slama L, Bambara A, Laurent C, Sangaré L, Sawadogo AB. Hepatitis B seroprevalence in HIV-infected patients consulting in a public day care unit in Bobo Dioulasso, Burkina Faso. Med Mal Infect 2013;43:202-7. [PMID: 23701923 DOI: 10.1016/j.medmal.2013.04.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
56 Matthews PC, Geretti AM, Goulder PJ, Klenerman P. Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa. J Clin Virol. 2014;61:20-33. [PMID: 24973812 DOI: 10.1016/j.jcv.2014.05.018] [Cited by in Crossref: 100] [Cited by in F6Publishing: 94] [Article Influence: 12.5] [Reference Citation Analysis]
57 Hønge BL, Jespersen S, Medina C, Wejse C, Erikstrup C. Comment on Lô et al.: Prevalence of hepatitis B markers in Senegalese HIV-1 infected patients: Comment on Lô et al. J Med Virol 2016;88:1653-4. [DOI: 10.1002/jmv.24455] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
58 Rusine J, Ondoa P, Asiimwe-Kateera B, Boer KR, Uwimana JM, Mukabayire O, Zaaijer H, Mugabekazi J, Reiss P, van de Wijgert JH. High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda. PLoS One 2013;8:e63303. [PMID: 23717409 DOI: 10.1371/journal.pone.0063303] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]